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This article, which was not indicated as 
written by David Healy, appears to provide 
a summary of the point of view espoused 
by Healy in his recent books, The Antide-
pressant Era and The Creation o/Psychophar-
macology. Harvard University Press, Cam-
bridge, Mass. I have written a review of the 
latter and some of the key ideas in the 
former in Science (Meltzer, 2002) which I 
refer the interested reader to for my reasons 
believing that Healy, a skilled polemiscist 
who is often loose with facts, must be read 
with great caution because of the innumer-
able inaccuracies and selective facts he 
choses to describe the role of industry, 
academia and government in the develop-
ment and marketing of the current genera-
tion of psychotropic drugs. This con-
densed version of his general point of view, 
while faithful to the gist of his argument, 
lacks the polish of his book. I find nothing 
in it that makes me want to add to my 
previously published commentary and cri-
tique. Statements like the comment that the 
pharmaceutical industry is "apparendy able 
to mould academic debate at will and to 
market psj'chiatric disorders more effec-
tively than they can make new therapeutic 
agents" yet they are the only source of new 
therapeutic agents used throughout the world 
(with considerable improvement in patient 
outcomes compared to the drugs which 
Healy advocates, e.g. cyproheptadine for 
depression and methylene blue for schizo-
phrenia), are self-contradictory. 
The final remarks in my review in Science, 
which refer to the suggestions included in 
this article that psychotropic drugs be made 
available without prescription may be worth 
quoting here. 
"The last chapter [of Healy, 2002] is the 
most original and most challenging part of 
Healy's book. Healy advances his belief 
that disorders like schizophrenia and manic-
depressive illness will largely disappear as 
targets for drug development and the clini-
cal activity of psychiatrists, based on pos-
sible advances in diagnosis and treatment, 
to be replaced by personality disorders or 
other limitations in the human character and 
intellectual capacity. Should these efforts be 
successful, he believes that people should 
be allowed to purchase these drugs without 
medical supervision. "Any future Rousseau 
should be able to try the interventions of 
twenty-first-century psychiatry in a setting 
that will enable him to decide freely whether 
they have anything to offer him (Healy 
2002, p389)." [From Meltzer, 2002] 
It is certainly possible that such 
Panglossian nostrums could be developed 
by a massive combined effort of industry, 
academia, and government. The use of such 
"life style drugs" as Healy calls them, if they 
become available, will present a great chal-
lenge to society. The abuse of alcohol or 
tobacco, certainly abetted by the spirits 
industry's marketing, apparently does not 
make Healy concerned about what could 
happen if such drugs became available 
without some form of control, medical or 
otherwise. Even acknowledging the harm 
sometimes done by clinicians who do not 
use psychotropic drugs well, I find such 
deregulation an extremely naive and danger-
ous proposal, one which stems from Healy's 
fascination with the Enlightenment and 
Romanticism, rather than a clear vision of 
what would happen in our culture, with its 
predilection for mind altering drugs and 
history of abuse of alcohol. "Caveat emp-
tor" applies to those who would alter 
mental states and readers of this challenging 
book alike." 
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